Leadership Team

Angela Lauretani has transitioned to AtomVie’s Leadership Team as the Senior Director of Finance and Administration from CPDC. Angela began working for CPDC as the Finance Controller in 2015 and transitioned to the Leadership team in 2018. In her current role, Ms. Lauretani is responsible for the Finance operations of AtomVie, including budgeting and commercialization efforts. She also oversees the Corporate Governance of the organization and the IT & Administration departments.

Angela has over 15 years of experience in financial management, previously employed by a publicly traded company (NYSE) for 10 years and began her professional career in public accounting with KPMG, where she obtained her Chartered Accountant, CA, CPA designation. Angela holds an Honours Bachelor of Commerce from McMaster University.

Bruno Paquin transitioned from his role as the CEO at CPDC to AtomVie. Bruno was pivotal in the successful launch of AtomVie, securing at least $40M series A funding for AtomVie. Prior to AtomVie, Bruno joined CPDC in November 2018 as the Director, Business Development, and then transitioned to become the CEO of CPDC as of November 2020. Under his leadership, CPDC achieved record revenues in 2019 and gained several new clients and presence in the radiopharmaceutical ecosystem. Previous to CPDC, Bruno was VP Business Development of Immuni T, where he was instrumental in growing the company by 400% over 7 years. Before Immuni T, Bruno was the Executive Director and Head of Business Development at Genizon Biosciences and received his PhD in Biochemistry from the Université de Montréal.

Constantinos Economou has transitioned into AtomVie as the Senior Director of Engineering and the Head of the new Facility Delivery Team. Constantinos is currently leading the construction and setup of AtomVie’s new state-of-the-art radiopharmaceutical CDMO facility.  Constantinos joined CPDC in 2010 holding various leadership roles in Engineering, and Manufacturing Operations.  Prior to joining CPDC Constantinos spent 11 years in the automotive sector leading manufacturing operations and projects in high-capacity manufacturing lines and automated systems. Over his 20+ Engineering career Constantinos has developed extensive expertise in automation systems, radiopharmaceutical facilities construction, commissioning, operations, and engineering. Constantinos is a Professional Engineer and holds an Honours Bachelor’s Degree in Mechanical Engineering as well as a Master of Science in Advanced Manufacturing from the University of Salford, Manchester, UK.

Dodi has more than 16 years of experience in Pharmaceutical Operations in global, big-pharma companies. Dodi is a business-oriented operations leader with a balanced blend of manufacturing, operations, supply chain, and operational excellence who helps pharmaceutical manufacturing organizations to meet their goals through comprehensive optimization processes directly contributing to the bottom line.

She has developed and successfully executed quality and safety cultural changes, improved employee satisfaction and enhanced organizational mindset changes while focusing on achievements.

Her experience also includes providing daily leadership on all aspects of operation, including EH&S, Project Management, Customer Satisfaction, QA, Engineering, MS&T, HR, Finance, and Maintenance. Dodi holds a bachelor’s degree in chemical engineering and a master’s degree in Environmental Engineering

Ghadeer Shubassi transitioned into AtomVie’s Leadership Team as the Associate Director of Business Development from the same role at CPDC. Ghadeer leads a Business Development team that is focused on client acquisitions, partnerships, marketing and communications. She joined CPDC on November 2019 as the Manager of Business Development and was promoted to the Associate Director in 2022. Prior to CPDC, Ghadeer gained experiences in commercialization of antibodies and biologics (at former CCAB: The Centre for The Commercialization of Antibodies & Biologics) as well as cell and gene therapies (at CCRM: Centre for Commercialization of Regenerative Medicine). She has 15+ years of professional experience in life sciences, with a focus on anti-cancer drugs. Ghadeer holds a PhD in Biochemistry from the University of Toronto followed by a post-doctoral fellowship in cancer signaling pathways at the FIRC Institute of Molecular Oncology; IFOM (Milan, Italy).

Jake Hasan, is an HR executive with over 20 years of business and HR experience in multiple industries including life sciences, manufacturing, consumer goods, and pulp and paper, with passion for aligning the people strategies with the business goals, enabling growth and success by engaging, motivating, and developing the most critical asset –People-.

Jake is a member of HRPA Ontario as a Certified Human Resources Executive (CHRE), holds a degree in industrial engineering, and diplomas in various HR topics. He is a dedicated father who enjoys travel and helping others.

Oscar Grilli transitioned from his role as the Vice President of Quality Operations at CPDC to AtomVie. He joined CPDC in 2019 as the Quality Assurance Director to support the hosting of an FDA inspection and the re-organization and staffing of the QA department. Oscar oversees the quality assurance, quality control, sterility assurance, quality validation, and analytical development departments. He leads his team towards ensuring compliance, championing continuous improvement initiatives, and supporting the daily manufacturing operations.

Oscar has more than 20 years of experience in leading Quality functions, mostly developed in multinational pharmaceutical companies, focused on quality assurance, aseptic processing, Statistical Process Control (SPC), and validation functions. He has developed and implemented validation programs for existing and new facilities, routine monitoring programs, training programs, improvement initiatives, and hosted regulatory inspections. Oscar holds a bachelor degree in Chemical Engineering, and an Ontario’s engineer professional license

Patrick Ruddock joined AtomVie’s parent company, CPDC, in 2011 as a Regulatory Affairs Associate and moved into his current role as Director, Regulatory and Clinical in 2022. Currently Patrick is responsible for all regulatory and clinical research activities at AtomVie. This includes investigational and commercial product submissions for AtomVie and its clients, interactions with regulators, establishment licensing, clinical trial management, pharmacovigilance, regulatory strategy and risk assessment.

Patrick has over 14 years’ experience with both CMC and clinical aspects of regulatory affairs, including working with radiopharmaceuticals, biologics and medical devices. He holds a M.Sc. (Microbiology) from the University of Ottawa and a post-graduate certificate in Regulatory Affairs from Humber College.

Rezwan Ashique has transitioned into AtomVie as the Vice President of Operations from the same role at CPDC.  Mr. Ashique joined CPDC in 2013 and held several progressive roles over the past 9+ years.  As the Head of the Operations, he oversees the process development/validation programs, routine manufacturing and overall supply chain at AtomVie.  Prior to joining CPDC, he led the establishment of the PERs Facility of Lantheus Medical Imaging in Mississauga, Ontario. Mr. Ashique holds an Hon. B.Sc. in Chemistry with a minor in Economics and an M.Sc. in Radiochemistry.  He has over 20 years of extensive experience in development, validation and routine manufacturing of sterile and ready-to-use diagnostic and therapeutic radiopharmaceuticals.